Stock Information
Charles River Laboratories International Inc (CRL)
Ticker Symbol: CRL
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $8,558.08 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -2.9563
Revenue (TTM): $81.59 M
Dividend Yield: N/A%
ROE: -4.4%
Latest News
-
LH vs. CRL: Which Stock Is the Better Value Option?
Fri, May 8, 2026 3:40 PM
-
Charles River Laboratories International, Inc. Q1 2026 Earnings Call Summary
Fri, May 8, 2026 12:27 AM
-
Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript
Thu, May 7, 2026 3:21 PM
-
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
Thu, May 7, 2026 2:20 PM
-
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
Thu, May 7, 2026 1:30 PM
-
GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions
Thu, May 7, 2026 1:00 PM
-
Charles River Laboratories (NYSE:CRL) Beats Q1 Estimates, Reaffirms Guidance
Thu, May 7, 2026 12:57 PM
-
Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates
Thu, May 7, 2026 12:50 PM
-
Charles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)
Thu, May 7, 2026 12:26 PM
-
Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations
Thu, May 7, 2026 12:04 PM
Key Financials
Financial data not available
